Richard E. Gregg
Keine laufenden Positionen mehr
Profil
Richard E.
Gregg served as Vice President-Clinical Discovery at Bristol Myers Squibb Co. He was the Chief Scientific Officer at Vitae Pharmaceuticals LLC from 2008 to 2016.
Prior to that, he worked as a Principal at the National Heart, Lung & Blood Institute.
Gregg received his undergraduate and graduate degrees from Iowa State University and his doctorate from Stanford University School of Medicine.
Ehemalige bekannte Positionen von Richard E. Gregg
| Unternehmen | Position | Ende |
|---|---|---|
| VITAE PHARMACEUTICALS INC | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2016 |
| National Heart, Lung & Blood Institute | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Ausbildung von Richard E. Gregg
| Iowa State University | Graduate Degree |
| Stanford University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Vitae Pharmaceuticals LLC
 Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vitae Pharmaceuticals LLC is a clinical-stage bio-pharmaceutical company, which engages in discovering and developing novel, small molecule drugs for diseases, including chronic kidney disease, diabetes and Alzheimer's disease, and autoimmune disorders, acute coronary syndrome, and immuno-oncology. The company was founded by John J. Baldwin, Bartosz A. Grzybowski, George M. Whitesides, and Eugene Shakhnovich on May 21, 2001 and is headquartered in Fort Washington, PA. | Health Technology |
| National Heart, Lung & Blood Institute | Government |
